Stevanato Group S.p.A. (STVN) CFO Marco Buys 7,997 Shares
Dal Lago Marco, CFO at Stevanato Group, purchased 2,356 shares in a recent transaction.
Reviewed by automated data checks against the source filing. How we make and check alerts
Dal Lago Marco, Chief Financial Officer at Stevanato Group S.p.A. ($STVN), bought 7,997 shares on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is down 0.8% after 1 week, up 15.8% after 1 month and up 10.7% to date (from the $17.08 close on Jun 12, 2026).
STVN
Stevanato Group S.p.A.
Key Points
- Dal Lago Marco, CFO of Stevanato Group, bought 2,356 shares of STVN on June 12, 2026.
- Stevanato Group's stock traded at $18.39 on Friday, with a market cap of $5.02 billion.
- Analysts recently set new price targets, with TD Cowen initiating a 'buy' rating at $25.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Dal Lago Marco, the Chief Financial Officer of Stevanato Group S.p.A. (NYSE: STVN), recently purchased 2,356 shares of the company. This transaction took place on June 12, 2026. The shares were acquired without a specific price being reported, and it was not part of a pre-arranged trading plan.
Insider Buying and Selling at Stevanato Group S.p.A.
In addition to Dal Lago Marco's purchase, other insiders at Stevanato Group have been active. On June 15, 2026, several insiders, including Karen Flynn and William Federici, sold 1,493 shares each at $17.09 per share. William Federici also bought 4,975 shares on June 12, 2026, alongside Dal Lago Marco's purchase.
Stevanato Group S.p.A. Stock Down 4.8%
Shares of NYSE:STVN traded near $18.39 on Friday. Stevanato Group has a market capitalization of approximately $5.02 billion. Its price-to-earnings ratio is 31.7, and it has a forward P/E of 21.9. The company has a beta of 0.776, indicating lower volatility compared to the market. The stock's 52-week range is from $12.89 to $28.00, with a 50-day moving average of $17.39 and a 200-day moving average of $19.57.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a 'buy' rating and a price target of $25. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a 'buy' rating and a $21 target. The consensus among analysts is a 'buy' rating, with a mean price target of $24.45 based on 10 opinions.
About Stevanato Group
Stevanato Group S.p.A. is a global company based in Piombino Dese, Italy. It operates in the healthcare sector, focusing on medical instruments and supplies. The company designs and manufactures products for the biopharma and healthcare industries, offering solutions such as syringes, vials, and diagnostic systems. Founded in 1949, Stevanato Group serves a wide range of clients across the pharmaceutical, biotechnology, and diagnostics sectors.
Bottom Line
The recent insider buying activity by Dal Lago Marco highlights ongoing interest in Stevanato Group's stock at the executive level. Investors often track such insider transactions to gauge confidence in a company's future prospects. It's important to note that these transactions are reported after the fact and may not reflect the insiders' current positions.
Related Filing Alerts
Source: Dal Lago Marco's Form 4 filing on $STVN (Jun 12, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts